Jeff Geschwind, MD – Innovator in Cancer Drugs Founder of Cage Pharma, Jeff Geschwind, MD focuses on cancer metabolism-targeting drugs, particularly glycolysis inhibitors. His research opens new possibilities for treating resistant tumors, showcasing his entrepreneurial spirit in oncology. https://www.linkedin.com/in/jeff-geschwind-037200174